Pearl River Capital, LLC Fate Therapeutics Inc Transaction History
Pearl River Capital, LLC
- $625 Million
- Q2 2024
Shares
2 transactions
Others Institutions Holding FATE
# of Institutions
183Shares Held
123MCall Options Held
15KPut Options Held
14K-
Redmile Group, LLC San Francisco, CA13.2MShares$31.2 Million2.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$25.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$24 Million0.0% of portfolio
-
Boxer Capital, LLC San Diego, CA8.22MShares$19.5 Million1.5% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.57MShares$13.2 Million0.6% of portfolio
About FATE THERAPEUTICS INC
- Ticker FATE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,000,304
- Market Cap $230M
- Description
- Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...